BRZE Braze, Inc. Insider Trading

General Counsel Wiseman sold 35.0K BRZE shares at $20.29 on 2026-04-09 ($710.2K); stock now -44.1% from 52-week high, 5 prior BRZE sells 90%-well-timed, company unprofitable.

Susan Wiseman, General Counsel, sold 35,000 shares at $20.29 for $710,150.00, reducing her holdings by 14.3%. The stock has fallen -44.1% from its 52-week high and is down -29.3% over the past 90 days, while her prior 5 sales at BRZE all showed negative 90-day returns with a 100% well-timed rate—a pattern suggesting consistent decision-making ahead of declines. Set against the company's unprofitability ($-36.0M net income in latest quarter) and stock weakness, the sale aligns with her historical timing pattern at this ticker. Current price of $20.61 sits in the lower half of the 52-week range, and the recent 90-day decline of -29.3% extends a longer downward trajectory in which her prior sales have fared well when measured at the 90-day mark.

CEO Magnuson sold 26.7K BRZE shares at $26.64; stock down 42.8% from 52-week high, company unprofitable.

CEO William Magnuson sold 26,698 shares for $711,234.72 on 2025-11-18, reducing his holdings by 3.7% to 694,746 shares post-transaction. The sale occurred as BRZE trades 42.8% below its 52-week high of $47.22 and -5.6% over the past month. At this same-ticker level, Magnuson's prior five sales at BRZE show mixed timing: three of five were well-timed at the 90-day mark, with recent sales on 2025-08-19 and 2024-11-18 each followed by substantial gains (+24.9% and +25.9% respectively 30 days out). Against that pattern, this sale occurs after a 30-day decline but in a stock down significantly from recent peaks. The company remains unprofitable (net income: $-27.9M) despite 25.8% annual revenue growth, which creates fundamental uncertainty around the valuation reset.

CEO Magnuson sells 24,325 shares at $25.94; stock -45.9% from 52-week high, company unprofitable with -$35.8M net income

Chief Executive Officer William Magnuson sold 24,325 shares at $25.94 on 2025-08-19, reducing his stake by 3.3% to 721,444 shares post-transaction. The sale occurred as BRZE trades -45.9% from its 52-week high of $47.22 and -26.5% over the past 90 days. This timing aligns with Magnuson's broader historical pattern at BRZE: his 5 prior trades at this ticker show 4 of 5 sales were well-timed at the 90-day mark, with negative subsequent returns indicating he consistently sold before declines. Materially, the company remains unprofitable with net income of -$35.8M against quarterly revenue of $162.1M, adding fundamental headwinds to the stock's technical weakness. The combination of CEO selling into significant drawdown, consistent pattern of well-timed exits at this ticker, and persistent unprofitability merits investor scrutiny of recent business developments.

CEO William Magnuson sold 25,089 shares of BRZE at $35.88 (total $900,193.32); stock now down 26.7% from 52-week high.

CEO William Magnuson sold 25,089 shares at $35.88 on 2025-05-19, reducing his holdings from 770,858 to 745,769 shares (-3.3%). At the transaction price, the stock was $1.25 above today's current price of $34.63, placing it 26.7% below the 52-week high of $47.22. While this constitutes a modest reduction in his stake, Magnuson's prior sales at BRZE show a timing pattern: 4 of 5 prior sells had negative 90-day returns, indicating his sales have typically preceded declines. The company remains unprofitable with a net loss of $27,911,000.00 in its most recent quarter despite 25.8% annual revenue growth, creating a backdrop of operational losses even as the business scales. The recent 30-day price recovery of +25.1% may reflect market attention to growth metrics, yet the broader context—stock down 14.8% over 90 days, company still burning cash—suggests sustained near-term weakness.

CEO William Magnuson sold 18,050 shares (18.0K shares) of Braze at $40.82 on 2025-02-18; holds 564,766 shares post-transaction.

CEO William Magnuson sold 18.0K shares for $736.8K, reducing his stake by 3.1% to 564.8K shares. His prior trades at Braze show a 4 of 5 well-timed pattern at the 90-day mark, with the most recent sale on 2024-11-18 followed by a +20.5% 90-day return (poorly timed), though earlier sales on 2024-08-16, 2024-05-17, 2024-05-16, and 2024-02-16 were followed by negative 90-day returns (well-timed). The company remains unprofitable with net income of $-27.9M despite 32.7% annual revenue growth, and the stock is currently -29.9% from its 52-week high of $57.98, down 9.8% over 30 days. The CEO's continued open-market sales—now his sixth cross-ticker sell in the track record and his sixth at Braze—occurs in a mixed valuation environment where the market has repriced the company significantly.

General Counsel Wiseman sold 14,000 shares at avg $45.52 on 2025-01-06; holds 199.5K post-sale.

Susan Wiseman, General Counsel, executed 2 separate sales totaling 14,000 shares for $637,303.37, reducing her stake by 6.6% to 199.5K shares. Wiseman's cross-ticker track record shows a 75.00% well-timed sell rate across 5 prior open-market sales, with 3 of 4 measurable same-ticker sales at BRZE showing negative 90-day returns (well-timed at 75%). The current sale occurs at $45.52 blended average price, 3.1% above the current market price of $44.15 but 23.8% below the 52-week high of $59.73. BRZE remains unprofitable (full-year net income $-27,911,000.00) despite strong revenue growth of 32.7% annually, creating elevated execution risk for a company trading at a compressed valuation. The sale timing warrants observation given the insider's demonstrated pattern of well-timed exit execution at this specific ticker.

Kleeger (Pres & CCO) sells 37,900 BRZE shares at $45.11 for $1.7M; retains 184.4K shares post-sale

Kleeger sold 37,900 shares at $45.11, reducing his stake by -17.0% of pre-transaction holdings to 184.4K shares. The stock has advanced +23.0% in the past 30 days and +21.8% over 90 days, trading 25.8% below its 52-week high of $59.73. His prior five sales at BRZE show mixed timing: two of five were well-timed (negative 90-day returns post-sale), while three resulted in subsequent gains. Across all tickers, his cross-ticker track record shows a 28.57% well-timed rate on seven prior sells (90-day returns averaging +1.8% overall, though individual timing outcomes are mixed). The company remains unprofitable (net income $-27.9M against $152.1M quarterly revenue), though revenue grew 32.7% year-over-year. The sale occurs as the stock has rebounded significantly from recent lows; the timing relative to fundamental performance and long-term stock price momentum warrants observation but does not constitute a clear directional signal given the insider's mixed track record at this ticker.

General Counsel sells 41,210 shares of BRZE at $45.09 on 2024-12-18; holds 199,520 shares post-transaction

Susan Wiseman, General Counsel of Braze, sold 41,210 shares at $45.09, reducing her stake from 240,730 to 199,520 shares, a -17.1% reduction. Her prior four sales at BRZE show 3 of 4 were well-timed at the 90-day mark (negative subsequent returns), though her cross-ticker track record over all tickers shows a 75.00% well-timed sell rate with an average 90-day return of -11.9%, suggesting a pattern of selling ahead of declines. The company is currently unprofitable with net income of $-27,911,000.00 against $152,052,000.00 in latest quarterly revenue, though full-year revenue growth stands at +32.7%, indicating high growth offset by near-term profitability challenges. Note: This filing involves a derivative-conversion transaction; the insider's complete position in derivative securities (Form 4 Table II) is not yet reflected in available data and should be reviewed for full position context.

CEO William Magnuson sold 17,933 shares of BRZE at $34.45; 4 of 5 prior BRZE sales were 90d well-timed; stock now $36.02, -39.7% from 52-week high.

CEO William Magnuson sold 17,933 shares for $617,791.85, reducing holdings from 600,749 to 582,816 shares. His timing pattern at BRZE is noteworthy: 4 of 5 prior sales at this ticker exhibited negative 90-day returns, meaning he consistently sold ahead of subsequent declines. His cross-ticker sell track record shows a 90d well-timed rate of 80.00% with an average 90d return of -4.1% after sales, reinforcing a pattern of selling before weakness. However, the company remains unprofitable with net income of -$23.0M despite revenue of $145.5M and 32.7% annual growth, creating an asymmetry where growth metrics cannot offset profitability concerns. The stock is currently -39.7% from its 52-week high, suggesting the insider's historical selling discipline may have preceded a material decline.

CFO Winkles sells 16,423 shares at $34.34–$36.01; 5 of 5 prior BRZE sells were 90-day well-timed; unprofitable company.

Winkles Isabelle, CFO, executed 4 separate sales totaling 16,423 shares for $571,858.85 on 2024-11-18 and 2024-11-20, reducing holdings by 7.6% to 199.8K shares. Her same-ticker history at BRZE shows a strong timing pattern: all 5 prior sales were well-timed at the 90-day horizon, with negative 90-day returns ranging from -1.2% to -20.8%, indicating she consistently sold before subsequent declines. The company remains unprofitable with net income of $-23.0M against quarterly revenue of $145.5M, though annual growth stands at 32.7%. Given her demonstrated ability to time exits at this specific ticker, this sale—occurring near the 52-week high—adds weight to the sell signal, though the current +16.5% 30-day price move suggests near-term strength.